Extraordinary progress has been made in the molecular, genetic, anatomical,
and pharmacological characterization of dopamine D-4, receptors in animal
and human brain. Clarification of the neurochemical and physiological roles
of these cerebral receptors is emerging, Postmortem neuropathological stud
ies have inconsistently linked D-4, receptors to psychotic disorders, and g
enetic studies have failed to sustain conclusive associations between D-4,
receptors and schizophrenia. However, associations are emerging between D-4
, receptors and other neuropsychiatric disorders, including attention defic
it hyperactivity disorder, mood disorders, and Parkinson's disease, as well
as specific personality traits such as novelty-seeking. Selective D-4, ago
nists and antagonists have been developed as useful experimental probes, D-
4, antagonists, so far, have proved ineffective in treatment of schizophren
ia, but testing in a broader range of disorders may yield clinically useful
drugs, D-4, receptors appear to have broad implications for the pathophysi
ology of neuropsychiatric illnesses and their improved treatment.